Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - ... 5 - 6 - 7 - 8 - 9 - 10 - 11 - ...
WAREHOUSE ESTATES BELGIUM S.C.A. [BE0003734481/WEB]   
[29/05/2018]

WAREHOUSE ESTATES BELGIUM S.C.A. : WEB SCA - ACQUISITION

WAREHOUSES ESTATES BELGIUM S.C.A. “We are building opportunities“ Communiqué de presse Information réglementée ... See more
 
RECTICEL [BE0003656676/REC]   
[29/05/2018]

RECTICEL : ANNUAL GENERAL SHAREHOLDERS’ MEETING OF RECTICEL

PRESS RELEASE Regulated information Brussels, 29 May 2018 – 14:00 CET ANNUAL GENERAL SHAREHOLDERS’ MEETING OF RECTICEL At the Annual General Shareholders’ Meeting of Recticel, which took place this morning, all proposed resolutions on the agenda1 of the Ordinary General Shareholders’ Meeting were ... See more
 
UCB [BE0003739530/UCB]   
[28/05/2018]

UCB : UCB Media Room: Cimzia FDA approval psoriasis

UCB Announces the Approval of CIMZIA® certolizumab pegol for ModeratetoSevere Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.The U.S. Food and Drug Administration’s FDA approval of CIMZIA® certolizumab pegol for use in moderatetosevere plaque psoriasis marks the entry of UCB into immunodermatologyCIMZIA Phase 3 psoriasis studies demonstrated significant and... See more
 
Gimv [BE0003699130/GIMB]   
[24/05/2018]

Gimv : Record investment year - Strong return as a result of significant growth of portfolio companies and capital gains on exits

Antwerp, 24 May 2018, 7:00 CET embargo Record investment year Strong return as a result of significant growth of portfolio companies and capital gains on exits Managing Director Koen Dejonckheere, on the past financial years results: The past year was again a very active one, with a record of nearly EUR 250 million of investments across our ... See more
 
UCB [BE0003739530/UCB]   
[23/05/2018]

UCB : UCB Media Room: U.S. Court of Appeals confirms val idity of patent for UCB's Vimpat®

U.S. Court of Appeals confirms validity of patent for UCBs Vimpat®Court of Appeals for the Federal Circuit affirms Delaware District Court’s decisionBrussels Belgium, May 23rd, 2018 – 18.00 CEST – UCB announces that in a decision released today, the Court of Appeals for the Federal Circuit CAFC has affirmed the Delaware District Court and confirmed the validity of U.S. patent RE38,551...